Moat Ross's Form 4 filing
Kiniksa Pharmaceuticals International, plc (KNSA) · filed Sep 8, 2025
- Accession no.
- 0001415889-25-023874
- Filed
- Sep 8, 2025
- Trade date
- Sep 4, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $124.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Moat RossCIK 0001857177 | Officer (CHIEF CORP. & COMM. OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | Class A Ordinary Share | SSaleDisposed | −3,523 | $35.31 | −$124,397.13 | 9,415 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.